Abstract
A rapid and simple analytical capillary zone electrophoresis (CZE) method has been developed and validated for quantitative determination of atypical antipsychotic drug risperidone in commercially available film-coated tablets. CZE was performed in an uncoated fused-silica capillary 40.2 cm total length x 75 µm i.d. (30 cm effective length) using a 20 mmol mL-1 sodium phosphate solution containing 0.1% triethylamine (v/v), pH 2.5 adjusted with ortho-phosphoric acid as background electrolyte. The applied voltage was +28 kV and UV detection at 236 nm, nitrazepam was used as internal standard (IS). Under these conditions, the separation of risperidone was achieved in less than 2.5 min. The method was validated and response was found to be linear with determination coefficient better than 0.999. The repeatability and intermediate precision expressed as relative standard deviation were less than 1.5 %. The accuracy, resulting from recovery experiments, was between 98.84 and 101.24 %. The active pharmaceutical ingredient was subjected to acid, alkaline and neutral hydrolysis and oxidative stress conditions. No interference from degradation products and also from tablet excipients was observed. The method was simple, precise and fast and could be successfully applied for determination of risperidone in pharmaceutical dosage forms and can be used for routine analysis in pharmaceutical industries. Furthermore, the method can be used as a stability-indicating method.
Keywords: Capillary zone electrophoresis, method validation, neuroleptic drug, pharmaceuticals, quantitative determination, risperidone.
Current Analytical Chemistry
Title:Development and Validation of a Capillary Zone Electrophoresis Method for the Quantitative Determination of Atypical Antipsychotic Risperidone in Pharmaceutical Dosage forms
Volume: 10 Issue: 2
Author(s): Fernanda N.I. Nagase, Aline E. Asato, Pedro López Garcia, Angel A. Gaona Galdos, Maria Ines R.M. Santoro, Erika R.M. Kedor-Hackmann and María Segunda Aurora-Prado
Affiliation:
Keywords: Capillary zone electrophoresis, method validation, neuroleptic drug, pharmaceuticals, quantitative determination, risperidone.
Abstract: A rapid and simple analytical capillary zone electrophoresis (CZE) method has been developed and validated for quantitative determination of atypical antipsychotic drug risperidone in commercially available film-coated tablets. CZE was performed in an uncoated fused-silica capillary 40.2 cm total length x 75 µm i.d. (30 cm effective length) using a 20 mmol mL-1 sodium phosphate solution containing 0.1% triethylamine (v/v), pH 2.5 adjusted with ortho-phosphoric acid as background electrolyte. The applied voltage was +28 kV and UV detection at 236 nm, nitrazepam was used as internal standard (IS). Under these conditions, the separation of risperidone was achieved in less than 2.5 min. The method was validated and response was found to be linear with determination coefficient better than 0.999. The repeatability and intermediate precision expressed as relative standard deviation were less than 1.5 %. The accuracy, resulting from recovery experiments, was between 98.84 and 101.24 %. The active pharmaceutical ingredient was subjected to acid, alkaline and neutral hydrolysis and oxidative stress conditions. No interference from degradation products and also from tablet excipients was observed. The method was simple, precise and fast and could be successfully applied for determination of risperidone in pharmaceutical dosage forms and can be used for routine analysis in pharmaceutical industries. Furthermore, the method can be used as a stability-indicating method.
Export Options
About this article
Cite this article as:
Nagase N.I. Fernanda, Asato E. Aline, Garcia López Pedro, Galdos A. Gaona Angel, Santoro Ines R.M. Maria, Kedor-Hackmann R.M. Erika and Aurora-Prado Segunda María, Development and Validation of a Capillary Zone Electrophoresis Method for the Quantitative Determination of Atypical Antipsychotic Risperidone in Pharmaceutical Dosage forms, Current Analytical Chemistry 2014; 10 (2) . https://dx.doi.org/10.2174/15734110113099990029
DOI https://dx.doi.org/10.2174/15734110113099990029 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Lobar Atrophy in Frontotemporal Dementia: Diagnostic and Prognostic Implications
Current Alzheimer Research Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
Current Alzheimer Research Epidemiology and Clinical Presentation of Stress-Related Peptic Damage and Chronic Peptic Ulcer
Current Molecular Medicine Valproate and Neuroendocrine Changes in Relation to Women Treated for Epilepsy and Bipolar Disorder: A Review
Current Medicinal Chemistry Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry Personalized Treatment of Obsessive-Compulsive Disorder: Radiology, EEG, Pharmacogenetics and Biochemistry
Current Pharmacogenomics and Personalized Medicine The Multifunctional Mesencephalic Locomotor Region
Current Pharmaceutical Design Withania somnifera Phytochemicals Confer Neuroprotection by Inhibition of the Catalytic Domain of Human Matrix Metalloproteinase-9
Letters in Drug Design & Discovery High Temporal Resolution Neuroimaging of Attentional and Somatosensory-Motor Processing in the Human Brain
Current Medical Imaging GSK-3 Inhibitors: Discoveries and Developments
Current Medicinal Chemistry TAU Aggregation is a Therapeutic Target for Alzheimers Disease
Current Alzheimer Research Cognitive Dysfunction in FMR1 Premutation Carriers
Current Psychiatry Reviews Patterns of Cognitive Impairment in Neurological Disease
Current Psychiatry Reviews Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Transgenic Mouse Models of Tauopathy in Drug Discovery
CNS & Neurological Disorders - Drug Targets The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia
Current Drug Targets - CNS & Neurological Disorders Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
Current Gene Therapy